Her reaction was a rash/ a big rash all around her midriff that itched and itched for about ten days; rash was red; feeling kind of lousy and washed out; feeling kind of lousy and washed out; had little bumps around her, a simple type thing; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  An 82-year-old female patient received BNT162b2 (BNT162B2), in 2021 as dose 3 (booster), single (Batch/Lot number: unknown) at the age of 82 years for covid-19 immunisation. The patient's relevant medical history included: "Coronary artery disease", start date: 2007 (unspecified if ongoing); "High cholesterol" (unspecified if ongoing); "she has is her heart problem" (unspecified if ongoing); "She has stents that were first put in during 2007", start date: 2007 (unspecified if ongoing). Concomitant medication(s) included: PLAVIX oral taken for coronary artery disease, start date: 2007; TOPROL oral, start date: 2009; ASPIRIN [ACETYLSALICYLIC ACID] oral taken for coronary artery disease, start date: 2007; ZETIA oral taken for coronary artery disease; PRAVASTATIN oral taken for blood cholesterol increased, start date: 2009. Vaccination history included: Moderna (Her bad reaction was that obviously after she had her vaccine doses the next day she was feeling kind of lousy and washed out. Dose 1), administration date: Mar2020, for COVID-19 Immunization, reaction(s): "feeling kind of lousy and washed out", "feeling kind of lousy and washed out"; Moderna (The rash was red and a little bit flat then also had little bumps around her, a simple type thing. Dose 1), administration date: Mar2020, for Covid-19 Immunization, reaction(s): "rash was red", "little bumps around her, a simple type thing"; Moderna (Dose 1), administration date: Mar2020, for Covid-19 Immunization, reaction(s): "big rash all around her midriff that itched and itched for about ten days"; Moderna (The rash was red and a little bit flat then also had little bumps around her, a simple type thing. Dose 2), administration date: 2020, for Covid-19 Immunization, reaction(s): "rash was red", "little bumps around her, a simple type thing"; Moderna (Her bad reaction was that obviously after she had her vaccine doses the next day she was feeling kind of lousy and washed out. Dose 2), administration date: 2020, for COVID-19 Immunization, reaction(s): "feeling kind of lousy and washed out", "feeling kind of lousy and washed out"; Moderna (Dose 2), administration date: 2020, for Covid-19 Immunization, reaction(s): "big rash all around her midriff that itched and itched for about ten days". The following information was reported: RASH PRURITIC (non-serious) with onset 2021, outcome "recovered", described as "Her reaction was a rash/ a big rash all around her midriff that itched and itched for about ten days"; MALAISE (non-serious), FATIGUE (non-serious) all with onset 2021, outcome "unknown" and all described as "feeling kind of lousy and washed out"; SKIN DISORDER (non-serious) with onset 2021, outcome "recovered", described as "had little bumps around her, a simple type thing"; RASH ERYTHEMATOUS (non-serious) with onset 2021, outcome "recovered", described as "rash was red". Therapeutic measures were not taken as a result of rash pruritic, rash erythematous, skin disorder.  Additional information: The patient got her second dose of Moderna COVID-19 vaccine two or three months after the first dose. She got her COVID-19 booster at the end of last year, maybe around the same time as it was now this year. On the next day of vaccinations, the patient felt kind of lousy and washed out. Then she broke into a big rash all around her midriff that itched and itched for about ten days. She did not receive any treatment of the rash and finally it went away by itself. The rash was red and a little bit flat then and also had little bumps around her, a simple type thing. This happened after each of her doses of COVID-19 vaccines. The patient was wondering whether she should go ahead with booster dose again as she was worried about the reactions occurred with previous covid vaccines.   The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.